75 Years of Exceptional Care and Innovation | Celebrate with Zoom backgrounds, email signatures and more!

Bethany P Cummings

Bethany P Cummings

Director and Associate Professor

Molecular Biosciences


Licenses
National Veterinary Medical Board
California Veterinary Medical Board
Education
2011, DVM, University of California, Davis, Davis, CA
2009, PhD, University of California, Davis
2005, BS, Brandeis University, Waltham, MA
Active Research Grants
Principal Investigator, Mapping Bile Acid Metabolism Across the Gut Microbiome in Response to Dietary Fiber, (Principal Investigator), NIH/NCCIH
Principal Investigator, Defining alpha cell proglucagon processing for type 2 diabetes treatment, (Principal Investigator), NIH/NIDDK
Principal Investigator, Harnessing the alpha-cell for diabetes treatment, (Principal Investigator), The Hartwell Foundation
Principal Investigator, Gut microbial bile acid metabolism and Alzheimer’s Disease, (Principal Investigator), NIH/NIA
Honors and Awards
2004 Howard Hughes Medical Institute Summer Fellowship
2005-2011 Veterinary Scientist Training Program Fellowship
2006 Achievement Rewards for College Scientists Fellowship
2007, 2008, 2009 Students Training in Advanced Research Summer Fellowship
2007-2009 NIH T32 STAR Fellowship
2007-2008 Yearlong Exposure to Advanced Research Fellowship
2008 Dr. Richard A. Freedland Fellowship Award for excellence in research
2008 Freedland Fellowship Award
2009 Dr. Charles E. Cornelius Memorial Fellowship for Excellence In Research
2010 Dr. Max Kleiber Award for a Distinguished Doctoral Thesis
2011 Dr. Wild Fellowship Award for Excellence In Research
2019 Hartwell Individual Biomedical Research Awardee
2019 Schwartz Research Fund Awardee
Specialty Focus
Molecular Biology
Ten Recent Publications

2022
Wise J, Cummings BP*.
A review of the 7-alpha-dehydroxylation pathway as an integral component of gut microbial bile acid metabolism and as a potential therapeutic target.

2022
Holm S, Peng SA, Holter MM, Cummings BP, Loftus JP.
Plasma glucagon and glucagon-like peptide- 1 in dogs with aminoaciduric canine hypoaminoacidemic hepatopathy syndrome: a pilot study.

2022
Bustamante J, Dawson T, Loeffler C, Marfori Z, Marchesi JR, Mullish BH, Thompson CC, Crandall KA, Rahnavard A, Allegretti JR*, Cummings BP*.
Impact of fecal microbiota transplantation on gut microbial bile acid metabolism in humans

2022
Holter MM*, Saikia M, Cummings BP.
Alpha cell paracrine signaling in the regulation of beta cell insulin secretion

2022
Buote NJ, Porter I, Loftus J, Cummings BP, Dakin GF.
Laparoscopic vertical sleeve gastrectomy in felines: a cadaveric feasibility study and clinical report in two cats.

2022
Holter MM, Phuong DJ, Lee I, Saikia M, Weikert L, Anderson ET, Fu Q, Zhang S, Sloop KW, Cummings BP*.
14-3-3-zeta contributes to the effect of enhanced beta cell GLP-1 receptor signaling to alter alpha cell proglucagon processing

2022
Noto JM, Piazuelo MB, Shah SC, Romero-Gallo, Hart JL, Di C, Carmichael JD, Delgado AG, Halvorson AE, Greevy RA, Wroblewski LE, Sharma A, Newton AB, Allaman MM, Wilson KT, Washington MK, Calcutt MW, Schey KL, Cummings BP, Flynn CR, Zackular JP, Peek RM.
Helicobacter pylori-induced inflammation and carcinogenesis is promoted by iron deficiency through targeted alterations in bile acid metabolism

2022
Wise J, Plescia T, Cummings BP, Lyo V.
Exploring the Relationship Between Bariatric Surgery and Inflammatory Bowel Disease: A Systematic Review

2021
Hutch CR, Stelmak D, Kanke M, Koch-Laskowski K, Cummings BP, Griffin C, Leix K, Sethupathy P, Singer K, Sandoval DA
Diet-dependent sex differences in the response to vertical sleeve gastrectomy

2021
Harlan B, Park HG, Spektor R, Cummings BP, Brenna JT, Soloway PD
Single-cell Chromatin Accessibility and Lipid Profiling Reveals a Metabolic Shift in Adipocytes Induced by Bariatric Surgery